Seven Grand Managers, Llc

Source: SEC Form 13F · as of Mar 2026

Seven Grand Managers, Llc holds 38 biotech & pharma companies tracked by BioSniper, totaling $113.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

38

Total value held

$113.9M

CompanySharesValue
NKTRNEKTAR THERAPEUTICS125,000$9.0M
DRUGBRIGHT MINDS BIOSCIENCES INC.120,000$8.8M
APGEApogee Therapeutics, Inc.100,000$8.4M
DNTHDianthus Therapeutics, Inc. /DE/100,000$8.4M
PVLAPALVELLA THERAPEUTICS, INC.60,000$7.5M
ABVXAbivax SA50,000$5.6M
SYRESpyre Therapeutics, Inc.100,000$5.0M
MANEVeradermics Incorporated74,750$4.7M
XENEXenon Pharmaceuticals Inc.75,000$4.4M
DFTXDefinium Therapeutics Inc.225,000$4.3M
EVMNEvommune, Inc.164,670$3.8M
GHGuardant Health Inc.40,000$3.7M
CAPRCAPRICOR THERAPEUTICS, INC.100,000$3.0M
ALHCAlignment Healthcare Inc.150,000$2.6M
KYMRKymera Therapeutics, Inc.30,000$2.5M
GPCRStructure Therapeutics Inc.50,000$2.4M
IRONDisc Medicine, Inc.35,000$2.2M
RLMDRELMADA THERAPEUTICS, INC.315,788$2.2M
AGMBAgomAb Therapeutics NV200,000$2.1M
MPLTMapLight Therapeutics, Inc.100,000$2.0M
SIONSionna Therapeutics, Inc.50,000$2.0M
KMTSKestra Medical Technologies Ltd.100,000$2.0M
ZBIOZenas BioPharma, Inc.100,000$2.0M
CMPSCOMPASS Pathways plc300,000$1.7M
ERASErasca, Inc.100,000$1.6M
GENBGenerate Biomedicines Inc.125,000$1.6M
CTMXCytomX Therapeutics, Inc.325,000$1.5M
COGTCogent Biosciences, Inc.35,000$1.3M
BCAXBicara Therapeutics Inc.62,500$1.2M
SABSSAB BIOTHERAPEUTICS, INC.275,000$1.1M
BIOABioAge Labs, Inc.50,000$875K
EIKNEikon Therapeutics Inc.80,000$846K
GLUEMonte Rosa Therapeutics, Inc.45,000$740K
CRVSCorvus Pharmaceuticals, Inc.50,000$732K
DYNDyne Therapeutics, Inc.35,000$635K
LRMRLarimar Therapeutics, Inc.125,000$563K
ARWRARROWHEAD PHARMACEUTICALS, INC.7,500$470K
AKTSAktis Oncology Inc.25,000$447K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Seven Grand Managers, Llc — Biotech 13F Holdings & Portfolio | BioSniper